Brief: Sun Pharma Advanced Research Co announces top-line results of action study for Baclofen GRS
Oct 6 (Reuters) - Sun Pharma Advanced Research Company Ltd
SPRC.NS
* Announces top-line results of phase III efficacy study &
duration of action study for Baclofen GRS
Source text for Eikon: ID:nBSEXk2Rq
Further company coverage: SPRC.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees